Skip to main content

Animations

MJFF Publications

3881 - 3890 of 8404 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    RESTRICTED
    Title: Targeting Mitochondrial Impairment in Parkinson's Disease: Challenges and Opportunities
    Journal Name: Frontiers in Cell and Developmental Biology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fcell.2020.615461
    Citation Count: 86
  • Summary Details
    OPEN
    Title: DeepSleep convolutional neural network allows accurate and fast detection of sleep arousal
    Journal Name: Communications Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s42003-020-01542-8
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Differential transcript usage unravels gene expression alterations in Alzheimer’s disease human brains
    Journal Name: npj Aging and Mechanisms of Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41514-020-00052-5
    Citation Count: 80
  • Summary Details
    OPEN
    Title: Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson’s Disease
    Journal Name: Metabolites
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/metabo11010029
    Citation Count: 106
  • Summary Details
    OPEN
    Title: Novel Associations of BST1 and LAMP3 With REM Sleep Behavior Disorder
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000011464
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Pimavanserin Treatment for Parkinson’s Disease Psychosis in Clinical Practice
    Journal Name: Parkinson's Disease
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2021/2603641
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Plasma-borne indicators of inflammasome activity in Parkinson’s disease patients
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-020-00147-6
    Citation Count: 63
  • Summary Details
    OPEN
    Title: Sequence of clinical and neurodegeneration events in Parkinson’s disease progression
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awaa461
    Citation Count: 82
  • Summary Details
    RESTRICTED
    Title: Response to: The need of reliable warning signs for dysphagia in Parkinson’s disease: an often-overlooked issue
    Journal Name: Expert Review of Gastroenterology & Hepatology
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1080/17474124.2021.1842195
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Pregabalin for neuropathic pain in primary care settings: recommendations for dosing and titration
    Journal Name: Postgraduate Medicine
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1080/00325481.2020.1857992
    Citation Count: 10
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.